Status:

UNKNOWN

Validation of the "ExSpiron©" in Patients With ALS

Lead Sponsor:

University Medical Center Groningen

Conditions:

Amyotrophic Lateral Sclerosis

Neuromuscular Diseases

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

Non-invasive ventilation (NIV) in patients diagnosed with amyotrophic lateral sclerosis (ALS) is nowadays common practice to provide comfort at the end stage of the disease. As complaints vary there i...

Detailed Description

Rationale: Non-invasive ventilation (NIV) in patients diagnosed with amyotrophic lateral sclerosis (ALS) is nowadays common practice to provide comfort at the end stage of the disease. As complaints v...

Eligibility Criteria

Inclusion

  • In order to be eligible to participate in this study, a subject must meet all of the following criteria:
  • Participants diagnosed with ALS requiring NIV
  • Age \> 18 of age; \< 85 years of age
  • An indication to start chronic NIV, hypercapnic respiratory failure (arterial carbon dioxide PaCO2 \> 6.0 kilo pascal (kPa) measured during daytime) or orthopnoea due to diaphragm paralysis.
  • Participants are able to provide feedback
  • Participants that are willing to participate and are able to consent and sign the informed consent form.

Exclusion

  • A potential subject who meets any of the following criteria will be excluded from participation in this study:
  • Clinically unstable
  • Acute respiratory failure
  • Participants with refractory hypotension, defined as systolic blood pressure less than 90 mmHg, despite inotropic agents
  • Uncontrolled cardiac ischemia or arrhythmias
  • Participants suffering from metastatic or terminal cancer
  • Other comorbid disease affecting respiration (ie obstructive sleep apnea, chronic obstructive pulmonary disease)
  • Participants lacking functional medical decision-making

Key Trial Info

Start Date :

September 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2025

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT04089696

Start Date

September 1 2025

End Date

September 1 2025

Last Update

November 29 2023

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.